Concepta PLC (AIM: CPT), the innovative UK personalised healthcare company and developer of myLotus®, the UK’s most accurate home-use fertility tracking and pregnancy self-testing system, announces final results for the year ended 31 December 2019.
Product Highlights
· myLotus first pregnancies and births announced
· Supply to Boots.com
· Leases and assets for Doncaster manufacturing site assigned to third party in April 2020
· Contract manufacturing agreement signed April 2020
Corporate Highlights
· Appointment of Madeleine Kennedy as Chief Financial Officer & Secretary in October 2019
· Appointment of Penelope McCormick as Chief Executive Officer in November 2019
· Appointment of Lyn Rees as Non-executive Director in November 2019
Financial Overview
• EBITDA loss £2.2m
• Cash at year end £0.62m
• £2.2m (net of issue expenses) share placing secured in April 2019
• £1.7m (net of issue expenses) share placing secured in April 2020
Commenting on Outlook, Penny McCormick, Chief Executive Officer of Concepta plc, said:
“As we roll out our commercial strategy and continually improve our cost base, we are confident of building sustainable growth, and an ability to invest in a portfolio that meets the needs of our customers. Underpinned by our increasing focus on the digital marketing and education effort from mid-2020, we expect to see good commercial traction of myLotus and take advantage of up-coming connected personal diagnostic technology innovation and industry know-how to drive our growth strategy.”
concepta